NKTR
#1859
Nektar Therapeutics - Common Stock
71.4 5 USD
0.00%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.13%
Monthly Change
+2.94%
6 month change
-2.48%
Year Change
-2.48%
Previous Close
70.6 8
Open
71.4 5
Low
71.4 5
High
71.4 5
Volume
65
Financials
- Market Capitalization 2.41 B
- Employee 63
- Founded 1990
- CEO N/A
- Website www.nektar.com
- Headquarter Delaware, United States
- FIGI BBG000BHCYJ1
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-9.07
Price to sales ratio
22.86
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1846 |  RARE Ultragenyx Pharmaceutical Inc. - Common Stock | 24.78 USD | -4.84% | -7.74% | -25.20% | -8.70% | 2.44 B USD | ||
| 1854 |  NRIX Nurix Therapeutics, Inc. - Common stock | 23.27 USD | -1.31% | -1.48% | -5.44% | +107.58% | 2.41 B USD | ||
| 1875 |  VCEL Vericel Corporation - Common Stock | 45.78 USD | -3.84% | +2.19% | +2.53% | +25.94% | 2.34 B USD | ||
| 1887 |  VERA Vera Therapeutics, Inc. - Class A Common Stock | 32.20 USD | -2.57% | -11.17% | -24.73% | +8.27% | 2.31 B USD |
Frequently asked questions about Nektar Therapeutics - Common Stock
What is the Nektar Therapeutics - Common Stock stock price today?
The current price of Nektar Therapeutics - Common Stock (NKTR) is 71.45. Over the past 24 hours, the stock has changed by -0.13%. Follow the NKTR chart for real-time price dynamics.
What is the stock ticker of Nektar Therapeutics - Common Stock?
Nektar Therapeutics - Common Stock trades under the ticker NKTR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Nektar Therapeutics - Common Stock stock going up?
NKTR has changed by +0.28% over the last week, +2.94% over the last month, and -2.48% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Nektar Therapeutics - Common Stock?
Nektar Therapeutics - Common Stock currently has a market capitalization of 2.41 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Nektar Therapeutics - Common Stock earnings last quarter?
Last quarter, Nektar Therapeutics - Common Stock reported earnings of -1.82 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Nektar Therapeutics - Common Stock revenue for the last quarter?
Nektar Therapeutics - Common Stock reported quarterly revenue of 10.86 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Nektar Therapeutics - Common Stock net income for the last quarter?
Nektar Therapeutics - Common Stock reported net income of -44.9 M for the last quarter. The previous quarter showed -36.08 M, which means net income changed by -24.46%.
How many employees does Nektar Therapeutics - Common Stock have?
As of the latest available data, Nektar Therapeutics - Common Stock has 63 employees. Workforce size can provide additional context about the company's scale and operations.
What is Nektar Therapeutics - Common Stock EBITDA?
Nektar Therapeutics - Common Stock EBITDA is -40.72 M, and its EBITDA margin is -374.89%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Nektar Therapeutics - Common Stock stock?
You can buy Nektar Therapeutics - Common Stock (NKTR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Nektar Therapeutics - Common Stock stock?
Investing in Nektar Therapeutics - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NKTR chart and related analysis on metatrader.com as part of your research.